Katalyze AI Aims to Transform the Pharmaceutical Sector with AI Agents with a 10.5 Million Dollar Investment

The AI-focused startup Katalyze AI announced a 10.5 million United States dollar (approximately 14.9 million Canadian dollar) seed investment aimed…

The company is developing an innovative platform that enables professionals in the pharmaceutical field to build teams of AI agents to perform tasks such as engineering, scientific research, and manufacturing…